Page last updated: 2024-12-07
palmitone
Description
palmitone: from leaves of Annona diversifolia; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
hentriacontan-16-one : A dialkyl ketone that is hentriacontane in which the hydrogens at position 16 are replaced by an oxo group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Flora | Rank | Flora Definition | Family | Family Definition |
Annona | genus | A plant genus of the family ANNONACEAE. It has edible fruit and seeds which contain acetogenins and benzoquinazoline and other alkaloids.[MeSH] | Annonaceae | The custard-apple plant family of the order Magnoliales, subclass Magnoliidae, class Magnoliopsida. Some members provide large pulpy fruits and commercial timber. Leaves and wood are often fragrant. Leaves are simple, with smooth margins, and alternately arranged in two rows along the stems.[MeSH] |
Cross-References
ID Source | ID |
PubMed CID | 94741 |
CHEBI ID | 5658 |
SCHEMBL ID | 352951 |
MeSH ID | M0384354 |
Synonyms (31)
Synonym |
CHEBI:5658 |
502-73-8 |
16-hentriacontanone |
C08379 |
palmitone |
nsc-953 |
nsc953 , |
hentriacontan-16-one |
dipentadecyl ketone |
pentadecyl ketone |
H0423 |
LMFA12000005 |
hentricontan-16-one |
hebtriacontanone |
ai3-22025 |
nsc 953 |
unii-gr7i8ic3no |
16-hentriacontane |
16-hebtriacontanone |
gr7i8ic3no , |
einecs 207-952-8 |
SCHEMBL352951 |
AKOS024390969 |
DTXSID00198239 |
mfcd00059222 |
FT-0736780 |
CS-0203837 |
Q27106854 |
D90862 |
AS-57185 |
A852531 |
Research Excerpts
Overview
Palmitone is a secondary metabolite of polyketide origin extracted from leaves of Annona diversifolia Saff.
Actions
Roles (2)
Role | Description |
metabolite | Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. |
anticonvulsant | A drug used to prevent seizures or reduce their severity. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Drug Classes (1)
Class | Description |
dialkyl ketone | |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (8)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 27.81
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 27.81 (24.57) | Research Supply Index | 2.30 (2.92) | Research Growth Index | 4.32 (4.65) | Search Engine Demand Index | 31.58 (26.88) | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 9 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |